glp-1 colorectal cancer death risk study november 2025 mortality If you are taking a GLP-1 for diabetes or weight loss, a new study found it may also be lowering Reduced risks of colorectal cancer

Scientific evidence: In a 2016 study researchers found that GLP-1 receptor activation led to a significant reduction in food intake, promoting satiety and curbing the desire to snack between meals (Jall et al., 2016)

Over the past few years, GLP-1 medications have fundamentally changed how we think about metabolic health

Beyond this window, patients should skip the dose and continue with the next scheduled injection

The following are considered clear liqui ds : Water Pulp-free clear fruit juice (e.g

In rare cases, weight loss injectables may slow gastric emptying to the extent that it increases the risk of aspiration, particularly in patients with swallowing disorders

A phase 1 proof-of-concept clinical trial was conducted in 53 people with T2DM and translated the favorable preclinical data into clinical facts